» Articles » PMID: 35167660

Impact of Zinc Deficiency During Prenatal And/or Postnatal Life on Cardiovascular and Metabolic Diseases: Experimental and Clinical Evidence

Overview
Journal Adv Nutr
Publisher Elsevier
Date 2022 Feb 15
PMID 35167660
Authors
Affiliations
Soon will be listed here.
Abstract

This review summarizes the latest findings, from animal models and clinical studies, regarding the cardiovascular and metabolic consequences in adult life of zinc deficiency (ZD) during prenatal and early postnatal life. The effect of zinc supplementation (ZS) and new insights about sex differences in the phenotype and severity of cardiovascular and metabolic alterations are also discussed. Zinc has antioxidant, anti-inflammatory, and antiapoptotic properties and regulates the activity of enzymes involved in regulation of the metabolic, cardiovascular, and renal systems. Maternal ZD is associated with intrauterine growth restriction and low birth weight (LBW). Breast-fed preterm infants are at risk of ZD due to lower zinc uptake during fetal life and reduced gut absorption capacity. ZS is most likely to increase growth in preterm infants and survival in LBW infants in countries where ZD is prevalent. Studies performed in rats revealed that moderate ZD during prenatal and/or early postnatal growth is a risk factor for the development of hypertension, cardiovascular and renal alterations, obesity, and diabetes in adult life. An adequate zinc diet during postweaning life does not always prevent the cardiovascular and metabolic alterations induced by zinc restriction during fetal and lactation periods. Male rats are more susceptible to this injury than females, and some of the mechanisms involved include: 1) alterations in organogenesis, 2) activation of oxidative, apoptotic, and inflammatory processes, 3) dysfunction of nitric oxide and renin-angiotensin-aldosterone systems, 4) changes in glucose and lipid metabolism, and 5) adipose tissue dysfunction. Safeguarding body zinc requirements during pregnancy, lactation, and growth periods could become a new target in the prevention and treatment of cardiovascular and metabolic disorders. Further research is needed to elucidate the efficacy of ZS during early stages of growth to prevent the development of these diseases later in life.

Citing Articles

Diet, Advanced Maternal Age, and Neonatal Outcomes: Results from the GESTAGE Study.

Puche-Juarez M, Toledano J, Hinojosa-Nogueira D, de Paco Matallana C, Sanchez-Romero J, Ochoa J Nutrients. 2025; 17(2).

PMID: 39861450 PMC: 11769228. DOI: 10.3390/nu17020321.


Short-Term Zinc Supplementation Stimulates Visceral Adipose Catabolism and Inflammation in Mice.

Huang X, Jiang D, Zhu Y, Fang Z, Feng B Nutrients. 2024; 16(21).

PMID: 39519550 PMC: 11547266. DOI: 10.3390/nu16213719.


Is oxidative stress - antioxidants imbalance the physiopathogenic core in pediatric obesity?.

Lupu A, Fotea S, Jechel E, Starcea I, Ioniuc I, Knieling A Front Immunol. 2024; 15:1394869.

PMID: 39176098 PMC: 11338799. DOI: 10.3389/fimmu.2024.1394869.


Intergenerational Impact of Parental Zinc Deficiency on Metabolic and Redox Outcomes in .

Sanusi K, Ibrahim K, Abubakar M, Shinkafi T, Ishaka A, Imam M Biology (Basel). 2024; 13(6).

PMID: 38927281 PMC: 11201253. DOI: 10.3390/biology13060401.


Early-life exposures and long-term health: adverse gestational environments and the programming of offspring renal and vascular disease.

Oulerich Z, Sferruzzi-Perri A Am J Physiol Renal Physiol. 2024; 327(1):F21-F36.

PMID: 38695077 PMC: 11687964. DOI: 10.1152/ajprenal.00383.2023.


References
1.
Uusitalo L, Kenward M, Virtanen S, Uusitalo U, Nevalainen J, Niinisto S . Intake of antioxidant vitamins and trace elements during pregnancy and risk of advanced beta cell autoimmunity in the child. Am J Clin Nutr. 2008; 88(2):458-64. DOI: 10.1093/ajcn/88.2.458. View

2.
Fernandez-Cao J, Warthon-Medina M, Moran V, Arija V, Doepking C, Serra-Majem L . Zinc Intake and Status and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Nutrients. 2019; 11(5). PMC: 6567047. DOI: 10.3390/nu11051027. View

3.
Wang H, Hu Y, Hao J, Chen Y, Su P, Wang Y . Maternal zinc deficiency during pregnancy elevates the risks of fetal growth restriction: a population-based birth cohort study. Sci Rep. 2015; 5:11262. PMC: 4459238. DOI: 10.1038/srep11262. View

4.
Reynolds L, Borowicz P, Caton J, Crouse M, Dahlen C, Ward A . Developmental Programming of Fetal Growth and Development. Vet Clin North Am Food Anim Pract. 2019; 35(2):229-247. DOI: 10.1016/j.cvfa.2019.02.006. View

5.
Tepaamorndech S, Kirschke C, Pedersen T, Keyes W, Newman J, Huang L . Zinc transporter 7 deficiency affects lipid synthesis in adipocytes by inhibiting insulin-dependent Akt activation and glucose uptake. FEBS J. 2015; 283(2):378-94. DOI: 10.1111/febs.13582. View